The global Kidney Transplant Market is estimated to be valued at US$ 86139.17 Mn in 2023 and is expected to exhibit a CAGR of 3.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The Kidney Transplant Market involves the transplantation of a kidney from a living or deceased donor to a patient with kidney failure or renal disease in order to prolong life. Kidneys removed from deceased organ donors are matched with recipients through a computerized matching program which takes into account blood type, tissue type and organ size. Physicians must also determine if there are existing health issues that could impact the success of the transplant. Post-transplant, patients require lifelong immunosuppressive drugs to prevent rejection of the new organ by the patient’s immune system.
Market key trends:
One of the major trends in the Kidney Transplant Market is the increasing use of AI and computing technologies to optimize transplant procedures and outcomes. AI algorithms are being used to analyze large datasets on donor and recipient characteristics in order to more accurately match organs and predict post-transplant risks. This helps minimize the chance of organ rejection and prolongs transplant success rates. Computing innovations are also being utilized to develop organ preservation solutions that extend the viable storage time of kidneys outside the body, allowing for more transplants from deceased donors. Extended organ preservation times improve availability and access to kidney transplants.
Porter’s Analysis
Threat of new entrants: The threat of new entrants in the kidney transplant market is moderate due high initial capital investment requirements and regulatory compliance costs.
Bargaining power of buyers: The bargaining power of buyers in the kidney transplant market is low due to the shortage of donor organs and life-saving nature of kidney transplants for end-stage renal disease patients.
Bargaining power of suppliers: The bargaining power of suppliers in the kidney transplant market is also low since buyers have few substitutes and suppliers face high regulatory hurdles.
Threat of new substitutes: The threat of new substitutes in the kidney transplant market is low as no other clinically proven therapies can replace kidney transplants yet for end-stage renal disease patients.
Competitive rivalry: high due to presence of large number of players.
Key Takeaways
The Global Kidney Transplant Market Size is expected to witness high growth, exhibiting CAGR of 3.1% over the forecast period, due to increasing prevalence of end-stage renal disease. The market size for 2023 is US$ 86139.17 Mn.
Regional analysis: North America is currently dominating the kidney transplant market and is expected to continue its dominance over the forecast period. This is attributed to factors such as increasing healthcare expenditures, presence of major kidney transplant centers, and growing demand for organ transplantation in the region. Asia Pacific is expected to exhibit fastest growth in the coming years owing to rising chronic kidney disease prevalence, increasing healthcare investments, and growing medical tourism in countries like India and China.
Key players operating in the kidney transplant market are Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc. Key players are focusing on new product launches, expansions, partnerships and acquisitions to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it